To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene COL4A6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
142 supporting clones for gene COL4A6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001847.2   .a 1 to 6571 1 to 6571 exact RefSeq, AAA   6571/6571
(100 %)
0 diff
(100 %id)
L22763   .a 3 to 1730 9 to 1736       1728/1736
(99 %)
7 diff
(99.6 %id)
U04845   .a 3 to 5723 9 to 5732 M170I tiling clone,   5724/5732
(99 %)
17 diff
(99.8 %id)
CN313334 embryonic stem cells, cell lines H1, H7, andH9 .a 110 to 532 36 to 458       423/458
(92 %)
6 diff
(98.7 %id)
BE544775 cervical carcinoma cell line, cervix .a 110 to 617 150 to 648   available from MGC,   499/796
(62 %)
24 diff
(97.0 %id)
CN313337 embryonic stem cells, cell lines H1, H7, andH9 .a 167 to 904 1 to 740       740/740
(100 %)
6 diff
(99.2 %id)
CN313331 embryonic stem cells, cell lines H1, H7, andH9 .a 287 to 870 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
AI889772 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 384 to 957 575 to 1       575/620
(92 %)
10 diff
(98.4 %id)
TI_1968233139   .a 408 to 1429 12 to 1032       1021/1208
(84 %)
9 diff
(99.3 %id)
TI_2194696899   .a 408 to 1530 11 to 1123   tiling clone,   1113/1240
(89 %)
21 diff
(98.4 %id)
AW082083 esophagus, squamous cell carcinoma .a 494 to 957 464 to 1       464/464
(100 %)
0 diff
(100 %id)
CN313340 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 521 to 887 1 to 367       367/367
(100 %)
1 diff
(99.8 %id)
TI_2194696891   .a 1131 to 2207 4 to 1073       1070/1244
(86 %)
19 diff
(98.5 %id)
TI_1968233135   .a 1134 to 2207 11 to 1078   AAA   1068/1246
(85 %)
20 diff
(98.4 %id)
CN313341 embryonic stem cells, cell lines H1, H7, andH9 .a 1155 to 1484 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
TI_1968235341   .a 1177 to 2288 11 to 1110       1104/1267
(87 %)
20 diff
(98.5 %id)
CN313332 embryonic stem cells, DMSO-treated H9 cellline .a 1335 to 1807 1 to 473       473/473
(100 %)
0 diff
(100 %id)
TI_2194696890   .a 1435 to 2621 22 to 1196       1175/1249
(94 %)
32 diff
(97.5 %id)
CN313350 embryonic stem cells, cell lines H1, H7, andH9 .a 1470 to 1728 1 to 259       259/259
(100 %)
0 diff
(100 %id)
TI_2194696905   .a 1733 to 2792 1072 to 18       1055/1227
(85 %)
8 diff
(99.4 %id)
CN313349 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1900 to 2551 1 to 652       652/652
(100 %)
0 diff
(100 %id)
AW380024 head_neck .a 1972 to 2086 1 to 117       117/134
(87 %)
8 diff
(94.1 %id)
TI_2194696894   .a 2109 to 3169 12 to 1065       1054/1215
(86 %)
20 diff
(98.4 %id)
TI_2194696897   .a 2238 to 3299 1067 to 15       1053/1219
(86 %)
12 diff
(99.1 %id)
CN313351 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2243 to 2744 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
CA396616 eye, RPE/choroid .a 2362 to 2973 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
TI_2194696908   .a 2416 to 3492 1 to 1077   tiling clone,   1077/1245
(86 %)
10 diff
(99.2 %id)
CA489342   .a 3077 to 3915 1 to 850       850/869
(97 %)
20 diff
(97.7 %id)
DR980712 placenta .a 3169 to 3387 1 to 218   AAA Submitted on the opposite strand 218/226
(96 %)
4 diff
(98.3 %id)
CN313339 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3254 to 4014 1 to 761       761/761
(100 %)
5 diff
(99.4 %id)
CN313348 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3269 to 3718 1 to 451       451/451
(100 %)
2 diff
(99.6 %id)
CN313352 embryonic stem cells, DMSO-treated H9 cellline .a 3437 to 3889 1 to 453       453/453
(100 %)
0 diff
(100 %id)
CA397764 eye, RPE/choroid .a 3474 to 3639 1 to 166       166/166
(100 %)
0 diff
(100 %id)
CN313343 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3563 to 4168 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
CN313344 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3628 to 4118 1 to 491       491/491
(100 %)
0 diff
(100 %id)
TI_2194696925   .a 3666 to 4783 1112 to 11       1102/1229
(89 %)
21 diff
(98.3 %id)
CX872164 embryonic stem .a 3829 to 4583 1 to 755       755/755
(100 %)
0 diff
(100 %id)
CN313353 embryonic stem cells, cell lines H1, H7, andH9 .a 4042 to 4741 1 to 700       700/700
(100 %)
1 diff
(99.9 %id)
TI_2194696895   .a 4137 to 5241 15 to 1114       1100/1266
(86 %)
13 diff
(99.0 %id)
CV571713 cornea, eye .a 4145 to 4569 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
BX342069   .a 4175 to 5232 1 to 1059       889/1061
(83 %)
62 diff
(94.2 %id)
TI_2194696907   .a 4248 to 5330 1088 to 11       1078/1228
(87 %)
7 diff
(99.5 %id)
AK300502 Prostate .a 4312 to 5255 1 to 944   tiling clone,   944/944
(100 %)
0 diff
(100 %id)
DA258208 caudate nucleus .a 4313 to 4900 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA738369   .a 4313 to 5076 2 to 759   capped   758/767
(98 %)
8 diff
(99.0 %id)
DA870383 Prostate .a 4313 to 4876 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA874396 Prostate .a 4313 to 4883 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB255531 uterus .a 4313 to 4889 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
AW603438 colon_normal .a 4360 to 4527 1 to 165       165/170
(97 %)
11 diff
(93.6 %id)
T28327 colon, embryo .a 4418 to 4714 1 to 297       297/297
(100 %)
4 diff
(98.7 %id)
CA488244   .a 4420 to 5274 1 to 872       872/892
(97 %)
23 diff
(97.5 %id)
TI_2194696901   .a 4438 to 5575 19 to 1144       1129/1261
(89 %)
13 diff
(99.0 %id)
EU182215   .a 4490 to 5176 1 to 687       687/687
(100 %)
2 diff
(99.8 %id)
DA748513   .a 4496 to 5059 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
TI_2194696892   .a 4631 to 5731 1105 to 8       1098/1269
(86 %)
5 diff
(99.7 %id)
CX872016 embryonic stem .a 4681 to 5450 1 to 770       770/770
(100 %)
0 diff
(100 %id)
DB269869 uterus .a 4729 to 5293 2 to 569   capped   568/568
(100 %)
6 diff
(99.0 %id)
BQ941056 large cell carcinoma, lung .a 4796 to 5708 24 to 945       922/952
(96 %)
34 diff
(96.5 %id)
CD635211   .a 4833 to 5434 1 to 602       602/602
(100 %)
3 diff
(99.6 %id)
CN313336 embryonic stem cells, cell lines H1, H7, andH9 .a 4871 to 5128 1 to 258       258/258
(100 %)
0 diff
(100 %id)
BX390747   .a 4875 to 5784 1 to 903       905/952
(95 %)
38 diff
(96.1 %id)
CN313346 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4951 to 5381 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
TI_2194696903   .a 4980 to 6134 6 to 1147   tiling clone,   1142/1265
(90 %)
22 diff
(98.3 %id)
BG680578 skin, squamous cell carcinoma .a 5005 to 5759 1 to 755       755/755
(100 %)
0 diff
(100 %id)
TI_2194695893   .a 5021 to 6134 1219 to 112       1108/1264
(87 %)
0 diff
(100 %id)
TI_1968231219   .a 5032 to 6134 1195 to 94     Submitted on the opposite strand 1102/1211
(90 %)
0 diff
(100 %id)
TI_2194699519   .a 5045 to 6134 1188 to 111   tiling clone,   1078/1279
(84 %)
0 diff
(100 %id)
CX866105 embryonic stem .a 5059 to 5775 1 to 717       717/717
(100 %)
0 diff
(100 %id)
CN313342 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5067 to 5776 1 to 710       710/710
(100 %)
2 diff
(99.8 %id)
CX755822 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 5083 to 5820 1 to 734     Submitted on the opposite strand 734/839
(87 %)
8 diff
(99.1 %id)
BM699063 eye, fetal eyes .a 5095 to 5667 1 to 573       573/573
(100 %)
0 diff
(100 %id)
TI_149282197   .a 5311 to 5983 113 to 793     Submitted on the opposite strand 681/1457
(46 %)
29 diff
(98.1 %id)
BF726518 eye, lens .a 5429 to 5918 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
TI_2194696922   .a 5455 to 6134 12 to 691       680/1246
(54 %)
1 diff
(100.0 %id)
CB050017 Prostate .a 5523 to 5972 3 to 452   fully sequenced,   450/452
(99 %)
6 diff
(98.7 %id)
AL701624 human skeletal muscle .a 5528 to 6015 1 to 488       488/488
(100 %)
6 diff
(98.8 %id)
CB050016 Prostate .a 5942 to 6571 659 to 30   tiling clone, fully sequenced, AAA   630/630
(100 %)
0 diff
(100 %id)
DB370955   .a 6008 to 6563 549 to 1       549/555
(98 %)
14 diff
(97.5 %id)
CX866025 embryonic stem .a 6089 to 6569 508 to 28   AAA   481/481
(100 %)
0 diff
(100 %id)
CN313347 embryonic stem cells, DMSO-treated H9 cellline .b 1 to 780 1 to 779   tiling clone,   779/779
(100 %)
5 diff
(99.4 %id)
NM_033641.2   .b 6 to 6702 1 to 6697 exact RefSeq, AAA   6697/6697
(100 %)
0 diff
(100 %id)
CN313335 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 23 to 169 1 to 147       147/147
(100 %)
0 diff
(100 %id)
CN313345 embryonic stem cells, cell lines H1, H7, andH9 .b 24 to 708 1 to 686       686/686
(100 %)
3 diff
(99.6 %id)
CD676232 eye, lens .b 26 to 641 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BM717791 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 35 to 382 1 to 348       348/492
(70 %)
1 diff
(99.8 %id)
CN313330 embryonic stem cells, cell lines H1, H7, andH9 .b 49 to 651 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BC000874 Cervix, carcinoma .b 84 to 1103 15 to 1033   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1019/1020
(99 %)
6 diff
(99.5 %id)
TI_2194695890   .b 99 to 1072 74 to 1041       968/1124
(86 %)
15 diff
(98.7 %id)
TI_2194699141   .b 99 to 1126 72 to 1086   tiling clone,   1015/1255
(80 %)
15 diff
(98.9 %id)
BC144669 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .c 1 to 6086 1 to 6086 S454P P1455S tiling clone,   6086/6086
(100 %)
3 diff
(100.0 %id)
TI_2194696909   .c 3066 to 4125 11 to 1061       1051/1215
(86 %)
19 diff
(98.5 %id)
TI_2194696896   .c 3141 to 4282 1145 to 12       1134/1260
(90 %)
17 diff
(98.7 %id)
DB260304 uterus .c 5525 to 6090 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BX331053   .c 5592 to 6501 929 to 13       917/929
(98 %)
0 diff
(100 %id)
R57437   .c 5705 to 5855 1 to 150       150/150
(100 %)
5 diff
(96.7 %id)
R73914 breast .c 5716 to 6127 15 to 429       415/429
(96 %)
6 diff
(98.7 %id)
BQ331638 lung_tumor .c 5833 to 6135 333 to 32       302/333
(90 %)
0 diff
(100 %id)
TI_151714920   .c 5855 to 6524 757 to 88   tiling clone, AAA   670/674
(99 %)
6 diff
(99.2 %id)
CA312783 Human Lung Epithelial cells, lung .c 5856 to 6515 677 to 19   AAA   659/674
(97 %)
1 diff
(99.9 %id)
BM931786 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5968 to 6515 1 to 546   AAA   546/546
(100 %)
1 diff
(99.9 %id)
AA193517.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 5994 to 6466 473 to 1     also hits gene TRIM26 473/473
(100 %)
2 diff
(99.6 %id)
AI889941 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 6040 to 6517 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AI889828 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 6074 to 6517 445 to 2       444/445
(99 %)
0 diff
(100 %id)
AI890815 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 6082 to 6517 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
AW452474   .c 6085 to 6515 448 to 18   AAA   431/431
(100 %)
1 diff
(99.8 %id)
AA910008 pooled .c 6093 to 6517 425 to 1       425/425
(100 %)
0 diff
(100 %id)
BX090415 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 6096 to 6515 434 to 15   AAA   420/420
(100 %)
1 diff
(99.8 %id)
CR743359 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 6097 to 6515 433 to 15   AAA   419/419
(100 %)
0 diff
(100 %id)
AI378422 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 6113 to 6512 403 to 4       400/403
(99 %)
0 diff
(100 %id)
AI680557 Prostate .c 6113 to 6524 416 to 5   tiling clone,   412/416
(99 %)
0 diff
(100 %id)
AA912712 pooled .c 6114 to 6515 402 to 1       402/402
(100 %)
0 diff
(100 %id)
T16713   .c 6162 to 6496 1 to 335     Submitted on the opposite strand 335/340
(98 %)
1 diff
(99.8 %id)
AA193595 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 6241 to 6517 278 to 1       278/282
(98 %)
3 diff
(99.0 %id)
AI273913 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 6259 to 6524 274 to 9       266/274
(97 %)
0 diff
(100 %id)
BC140855 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .d 1 to 5987 1 to 5987 S454P tiling clone,   5987/5987
(100 %)
2 diff
(100.0 %id)
TI_1968233199   .d 3570 to 4641 1074 to 7       1068/1243
(85 %)
7 diff
(99.5 %id)
TI_1968235339   .d 3748 to 4796 1066 to 20       1047/1243
(84 %)
2 diff
(99.9 %id)
TI_2194696924   .d 3865 to 4641 789 to 14     Submitted on the opposite strand 776/1191
(65 %)
16 diff
(98.7 %id)
TI_1968235317   .d 3880 to 5110 11 to 1227       1217/1292
(94 %)
20 diff
(98.5 %id)
AK302734 testis .e 1 to 1031 1 to 1031 exact tiling clone,   1031/1031
(100 %)
1 diff
(100.0 %id)
DC402227 testis .e 1 to 570 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC422095 uterus .e 121 to 687 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
CR605243 HeLa cells Cot 25-normalized .f 1 to 2075 2 to 2076 exact tiling clone,   2076/2076
(100 %)
0 diff
(100 %id)
BG330884 large cell carcinoma, lung .g 1 to 388 1 to 386 I3* tiling clone,   762/939
(81 %)
29 diff
(97.0 %id)
TI_151756082   .g 209 to 677 600 to 132   tiling clone,   469/1040
(45 %)
5 diff
(99.6 %id)
CN313333 embryonic stem cells, cell lines H1, H7, andH9 .h 1 to 610 1 to 610 exact tiling clone,   610/610
(100 %)
0 diff
(100 %id)
BC005305 Prostate .i 1 to 1780 1 to 1779 exact tiling clone, available from MGC, AAA   1779/1779
(100 %)
5 diff
(99.8 %id)
BE973561 Prostate .i 21 to 738 1 to 707 exact available from MGC,   707/868
(81 %)
32 diff
(96.4 %id)
BT007228   .i 138 to 346 12 to 220       209/222
(94 %)
7 diff
(96.9 %id)
CV030024 mixed .i 138 to 347 12 to 221       210/394
(53 %)
7 diff
(98.3 %id)
BF674621 Prostate .i 140 to 572 229 to 662   available from MGC,   434/880
(49 %)
28 diff
(96.9 %id)
BC070203 Prostate .j 1 to 1875 1 to 1874 exact tiling clone, available from MGC, AAA   1874/1874
(100 %)
5 diff
(99.8 %id)
DA565207 heart .j 155 to 721 2 to 568 exact capped   567/567
(100 %)
1 diff
(99.9 %id)
CN313338 embryonic stem cells, DMSO-treated H9 cellline .k 1 to 812 1 to 815 exact tiling clone,   815/815
(100 %)
4 diff
(99.6 %id)
DA492480 brain .l-u 1 to 570 2 to 571 exact tiling clone, capped   570/571
(99 %)
1 diff
(99.9 %id)
TI_1968233179   Gene COL4A6, variant not shown         Submitted on the opposite strand    
CD635210   Gene COL4A6, variant not shown         Suspected internal deletion, this clone was ignored    
D21337   Gene COL4A6, variant not shown         Suspected internal deletion, this clone was ignored    
DN919442   Gene COL4A6, variant not shown              
DN919443   Gene COL4A6, variant not shown              
AW627863 2 pooled high-grade transitional celltumors, genitourinary tract Gene COL4A6, variant not shown              
BG740770 skin Gene COL4A6, variant not shown              
BI259606 cervical carcinoma cell line, cervix Gene COL4A6, variant not shown              
DB367841   Gene COL4A6, variant not shown         This clone was ignored    
AU130690   Gene COL4A6, variant not shown       capped This clone was ignored    
DB285032 uterus Gene COL4A6, variant not shown       capped      
DB352724 uterus Gene COL4A6, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI